Varivax is effective, despite rise in breakthroughs. (Asthma, Eczema Raise Vaccine Failure Risk).(Brief Article): An article from: Family Practice News
This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2002. The length of the article is 1912 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Varivax is effective, despite rise in breakthroughs. (Asthma, Eczema Raise
List Price: $ 5.95
Price: $ 5.95
Varivax is effective, despite rise in breakthroughs. (Asthma, Eczema Raise Vaccine Failure Risk).(Brief Article): An article from: Family Practice News
More Asthma Eczema Products
Orignal From: Varivax is effective, despite rise in breakthroughs. (Asthma, Eczema Raise Vaccine Failure Risk).(Brief Article): An article from: Family Practice News
No comments:
Post a Comment